page contents

Bristol-Myers tries to salvage $74 billion deal with Celgene. Meets with investors in NYC, Boston

Bristol-Myers Squibb has been meeting with shareholders in Boston and New York over the last two weeks to try to salvage its $ 74 billion purchase of cancer drugmaker Celgene, the biggest acquisition announced so far this year.

<meta id="speakablemeta3" item…
Business News

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.